IRWD - Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 misses by $0.07 revenue of $117.13M beats by $6.96M
Ironwood Pharmaceuticals press release (NASDAQ:IRWD): Q4 Non-GAAP EPS of $0.27 misses by $0.07. Revenue of $117.13M (+0.4% Y/Y) beats by $6.96M. Guidance: FY22 The company expects the revenue to be between $420M -$430M (consensus of $426.90M). Adjusted EBITDA expected to be >$250M
For further details see:
Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 misses by $0.07, revenue of $117.13M beats by $6.96M